Description: Borregaard ASA develops, produces, and markets specialized biomaterials, biochemicals, and biofuels in Norway, rest of Europe, the United States, Asia, and internationally. It operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for a range of applications, such as agrochemicals, batteries, industrial binders, and construction; and biovanillin for flavor and fragrance companies, as well as for food and beverage industry. The BioMaterials segment offers specialty cellulose for use as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products; and cellulose fibrils for industrial applications. The Fine Chemicals segment provides fine chemical intermediates for contrast agents; and bioethanol. Borregaard ASA was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
Home Page: www.borregaard.com
Hjalmar Wessels vei 6
Sarpsborg,
1701
Norway
Phone:
47 69 11 80 00
Officers
| Name | Title |
|---|---|
| Mr. Per Arthur Sørlie | Pres & CEO |
| Mr. Per Bjarne Lyngstad | Chief Financial Officer |
| Mr. Knut-Harald Bakke | Director Investor Relations |
| Mr. Rolf Sveinung Heggen | Gen. Counsel |
| Mr. Dag Arthur Aasbø | Sr. VP of Organisation & Public Affairs |
| Mr. Tom Erik Foss-Jacobsen | Exec. VP of BioSolutions |
| Mr. Gisle Løhre Johansen | Exec. VP of Speciality Cellulose & Fine Chemicals |
| Ms. Tuva Barnholt | Sr. VP of Strategic Sourcing |
| Mr. Pål Romberg | Exec. VP of Exilva |
| Ms. Kristin Misund | Sr. VP of R&D and Bus. Devel. |
Exchange: OL
Country: NO
Currency: Norwegian Krone (kr)
| Forward PE: | 17.5747 |
|---|---|
| Trailing PE: | 19.0476 |
| Price-to-Book MRQ: | 4.0139 |
| Price-to-Sales TTM: | 2.3495 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1072 |